Related Experiment Video
Updated: May 15, 2026

05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
A genetic algorithm-support vector machine method with parameter optimization for selecting the tag SNPs
1Akören Vocational School, Selçuk University, 42460 Akören, Konya, Turkey. ilhan@selcuk.edu.tr
Journal of Biomedical Informatics
|December 25, 2012
Summary
Selecting tag Single Nucleotide Polymorphisms (SNPs) is crucial for cost-effective disease-gene association studies. A new GA-SVM method with parameter optimization offers improved accuracy in identifying representative SNPs.
Area of Science:
- Genetics
- Bioinformatics
- Computational Biology
Background:
- Millions of Single Nucleotide Polymorphisms (SNPs) in the human genome offer potential for disease-gene association studies.
- High genotyping costs for millions of SNPs necessitate selecting representative subsets (tag SNPs).
- Existing tag SNP selection methods exhibit limited prediction accuracy.
Purpose of the Study:
- To develop a novel method for accurate tag SNP selection.
- To enhance prediction accuracy in identifying representative SNPs for genetic studies.
Main Methods:
- A new method, GA-SVM, integrating a genetic algorithm (GA) for tag SNP selection and support vector machine (SVM) for prediction.
- Particle Swarm Optimization (PSO) algorithm used to optimize SVM parameters (C and γ).
Main Results:
- Experimental testing on diverse datasets demonstrated superior performance of the GA-SVM method.
- The developed method achieved higher prediction accuracy in identifying tag SNPs compared to existing approaches.
Conclusions:
- The GA-SVM method with parameter optimization presents a significant advancement in tag SNP selection.
- This approach offers improved accuracy and cost-effectiveness for large-scale genetic association studies.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Modern Molecular Taxonomy
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
